Cybin Inc (CYBN) Business News Sept. 08, 2025, 11:30 UTC Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder Full text
There are no comments here yet...